Galera Therapeutics Inc - MO St. Louis, Saint Louis 63132

Galera Therapeutics Inc entered the industry of Commercial Biotechnical Research in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Al Beardsley by calling (314) 615-6324 during business hours. You can also write to the business’ Branch at 1100 Corporate Square Drive, Saint Louis, Missouri MO 63132. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Galera Therapeutics Inc
Representative: Al Beardsley
Place of Business: 1100 Corporate Square Drive, Saint Louis, MO 63132
Contact Number: (314) 615-6324
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Branch
Market Type: B2B (Business to Business)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Galera Therapeutics Inc is a company operating from St. Louis, Missouri providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Galera Therapeutics Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Al Beardsley at (314) 615-6324 for related queries, or to locate its Branch using the coordinates 38.675758,-90.401682.

The Branch can also be found at the street address 1100 Corporate Square Drive in Saint Louis, Missouri 63132 and can be engaged online through the company website at , the company Twitter , and Facebook page .